The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Summary

A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"

Timeline

Start

2006-09

Primary completion

2010-11

Completion

2011-06

Outcome

Met primary endpoint

Stopped: “Sponsor's decision”

registry p <0.0001; Mean Difference (Net) 49.8 (95% CI 39.55 to 60.15); t-test, 2 sided NCT00467896 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Iloprost	Other / unclassified	5 ug	Inhaled

Indications